Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-25 @ 4:24 PM
NCT ID:
NCT02161757
Group ID:
EG001
Title:
Tralo 300 mg Q4W
Description:
Tralokinumab 300 mg administered subcutaneously Q4W over a 52-week treatment period (up to 13 doses). Follow-up visits were conducted at Weeks 56 and 72.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
39
Serious Number At Risk:
404
Other Number Affected:
145
Other Number At Risk:
404
Study:
NCT02161757
Results Section:
NCT02161757
Adverse Events Module:
NCT02161757